Evaluation of [76Br]FBAU 3′,5′-dibenzoate as a lipophilic prodrug for brain imaging
- 1 July 2002
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 29 (5) , 527-535
- https://doi.org/10.1016/s0969-8051(02)00324-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Use of 5-[76Br]bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour modelEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Regenerating the damaged central nervous systemNature, 2000
- Prodrugs for improved CNS deliveryAdvanced Drug Delivery Reviews, 1996
- Synthesis of 2′-fluoro-5-[11C]-methyl-1-β-d-arabinofuranosyluracil ([11C]-FMAU): A potential nucleoside analog for in vivo study of cellular proliferation with PETNuclear Medicine and Biology, 1995
- High performance liquid chromatography of Carbon-11 labeled thymidine and its major catabolites for clinical PET studiesNuclear Medicine and Biology, 1994
- Enhanced Delivery of 5-Iodo-2′-Deoxyuridine to the Brain ParenchymaPharmaceutical Research, 1992
- Effects of 5′-Ester Modification on the Physicochemical Properties and Plasma Protein Binding of 5-Iodo-2′-deoxyuridinePharmaceutical Research, 1991
- Cell proliferation after ischemic injury in gerbil brainCell and tissue research, 1985
- Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA ReplicationScience, 1982
- Detection of DNA Synthesis in Intact Organisms with Positron-Emitting [ Methyl - 11 C]ThymidineProceedings of the National Academy of Sciences, 1972